← Back to headlines
Johnson & Johnson Acquires Firefly Bio for $1 Billion
Johnson & Johnson has announced its acquisition of Firefly Bio, a company specializing in cancer drug technology development, for $1 billion in cash. This strategic move aims to bolster J&J's oncology pipeline.
8 Jun, 13:33 — 8 Jun, 13:33
Sources
Showing 1 of 3 sources
Coverage Timeline
First report: seeking-alpha · 8 Jun, 12:42|Full coverage: 3 · 51m|Window: 51m
Left-leaningCenterRight-leaning
Related Stories
Bank of Korea Raises Interest Rates to 3% Amid Persistent Inflation
11m ago
Singapore Police Raid Iron Ore Trader Radiant World Amid Expanding Fraud Investigation
20m ago
Qantas Profit Falls as Fuel Costs Surge Despite Share Gain
38m ago
Bank of Japan Official Advocates for Timely Interest Rate Increase
40m ago